Regis Technologies
Edward Franklin is an accomplished Chromatography Applications Scientist at Regis Technologies since March 2018, bringing significant expertise from a previous role as Senior Scientist at Restek Corporation from 2012 to February 2018. Edward earned a Doctor of Philosophy in Analytical Chemistry from the University of North Carolina at Chapel Hill, where studies were completed between 2007 and 2012. Additionally, Edward holds a Master of Science in Forensic Science & Law from Duquesne University, completed in 2007, and a Bachelor of Arts in Biochemistry from the same institution, graduated in 2006.
Regis Technologies
Regis Technologies, Inc. partners with pharmaceutical and biotechnology companies to help advance drug candidates to market. Our services streamline and support your discovery, lead molecule development and drug commercialization – from process development and analytical development, to stability services and cGMP API manufacturing. Our facilities are routinely inspected by the FDA and other global regulatory authorities. With our extensive organic chemistry & separations expertise, Regis also manufactures an innovative line of proprietary chromatography products sold throughout the world. Regis is privately owned and operated and has been in business in the Chicagoland area since 1956.